Concepedia
Statistics
Publications
14
Citations
1.3K
H-Index
13
Active since
2008
Affiliations
Sunesis (United States)(Current)
Stanford University
Assembly Biosciences (United States)
Clinical Trials New Zealand
University of Toronto
Marc Evanchik is an author at Sunesis (United States) specializing in medicine, pharmacology, and drug discovery.
Top concepts
MedicinePharmacologyBiochemistryDrug DiscoveryPharmacotherapyCardiologyPhysiologyCell BiologyHeart FailureTumor Biology
Publications per year
2008–2022
A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice
Eric M. Green, Hiroko Wakimoto, Robert L. Anderson et al. · Science · 2016 · 691 citations · Full text
A Small Molecule Inhibitor of Sarcomere Contractility Acutely Relieves Left Ventricular Outflow Tract Obstruction in Feline Hypertrophic Cardiomyopathy
Joshua A. Stern, Svetlana Markova, Yu Ueda et al. · PLoS ONE · 2016 · 125 citations · Full text
Molecular Pharmacology, Cardiac Muscle, Heart Failure +13
<i>In vitro</i>and<i>in vivo</i>pharmacokinetic characterization of mavacamten, a first-in-class small molecule allosteric modulator of beta cardiac myosin
Mark P. Grillo, John C. L. Erve, Ryan A. Dick et al. · Xenobiotica · 2018 · 99 citations · Full text
Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry Eye
Min Zhong, Thomas R. Gadek, Minna Bui et al. · ACS Medicinal Chemistry Letters · 2012 · 94 citations · Full text
Ocular Disease, Immunology, Immunologic Mechanism +17
SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivo
Jennifer P. Arbitrario, Brian J. Belmont, Marc Evanchik et al. · Cancer Chemotherapy and Pharmacology · 2009 · 66 citations
Potent Anti-tumor Activity, Novel Therapy, Medicine +10
1–5 of 14